Login
$DNLI
$18.08 -$0.66 (3.52%) Live

$DNLI 8-K/A SEC Filings

Filed On Filing
10 Feb 2021 8-K/A: Departure/Election of Directors or Officers; Compensation

On January 8, 2021, Nancy Thornberry was appointed to the Board of Directors (the “Board”) of Denali Therapeutics Inc. (the “Company”). The election of Ms. Thornberry was reported under Item 5.02 of the Company’s Current Report on Form 8...

20 Aug 2020 8-K/A: Submission of Matters to a Vote of Security Holders

As previously reported in the Original Form 8-K, in a non-binding advisory vote on the frequency of future say on pay votes held at the 2020 Annual Meeting, 41,684,618 shares voted for one year, 29,849 shares voted for 2 years, 39,535,17...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support